In 2024, a study from The BMJ made national headlines after it linked Depo-Provera to an increased risk of brain tumors called meningiomas. Researchers found that patients who received injections for at least one year could be 5.6x more likely to develop a meningioma in their lifetimes. Quickly after the study was published, thousands of […]
Depo-Provera: Why Was the U.S. Last To Know the Risks? Read More »
The ongoing brain tumor lawsuit against Pfizer, the maker of Depo-Provera, has grown immensely within the past year. Survivors have filed thousands of new claims in record-breaking time because of recent developments—and, according to legal experts, many more women are expected to join the lawsuit in the next few months. The lawsuit started in 2024
In September 2025, researchers from Case Western Reserve University and the Cleveland Clinic published a new study linking the Depo-Provera birth control shot with an increased risk of being diagnosed with a meningioma—a common type of brain tumor. Featured in the prestigious medical journal JAMA Neurology, this is the third academic study to identify a
New Medical Study Links Depo-Provera to Meningioma Risk Read More »
In March 2024, a well-respected medical journal published a study linking the Depo-Provera birth control shot (known as medroxyprogesterone) to an increased risk of brain tumors called meningiomas. The British Medical Journal found that using the Depo shot for at least one year could make women over FIVE TIMES more likely to develop meningiomas than
British Medical Journal Links the Depo Shot to Brain Tumors Read More »
